Joshi BH - Search Results

1

A review of studies on targeting interleukin 4 receptor for central nervous system malignancy.

Puri S, Puri S, Mahapatra AK, Hussain E, Sarkar C, Sinha S, Joshi BH. Puri S, et al. Among authors: joshi bh. Curr Mol Med. 2009 Aug;9(6):732-9. doi: 10.2174/156652409788970661. Curr Mol Med. 2009. PMID: 19689300 Review.

2

Expression and structure of interleukin 4 receptors in primary meningeal tumors.

Puri S, Joshi BH, Sarkar C, Mahapatra AK, Hussain E, Sinha S. Puri S, et al. Among authors: joshi bh. Cancer. 2005 May 15;103(10):2132-42. doi: 10.1002/cncr.21008. Cancer. 2005. PMID: 15830341 Free article.

3

Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.

Suzuki A, Puri S, Leland P, Puri A, Moudgil T, Fox BA, Puri RK, Joshi BH. Suzuki A, et al. Among authors: joshi bh. PLoS One. 2019 May 23;14(5):e0217131. doi: 10.1371/journal.pone.0217131. eCollection 2019. PLoS One. 2019. PMID: 31120964 Free PMC article.

4

A Novel Recombinant Modified Vaccinia Ankara Virus expressing Interleukin-13 Receptor α2 Antigen for Potential Cancer Immunotherapy.

Sato Y, Vatsan R, Joshi BH, Husain SR, Puri RK. Sato Y, et al. Among authors: joshi bh. Curr Mol Med. 2023 Mar 31. doi: 10.2174/1566524023666230331085007. Online ahead of print. Curr Mol Med. 2023. PMID: 36999709

5

Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.

Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK. Joshi BH, et al. Vitam Horm. 2006;74:479-504. doi: 10.1016/S0083-6729(06)74019-5. Vitam Horm. 2006. PMID: 17027527 Review.

6

In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.

Joshi BH, Leland P, Asher A, Prayson RA, Varricchio F, Puri RK. Joshi BH, et al. Cancer Res. 2001 Nov 15;61(22):8058-61. Cancer Res. 2001. PMID: 11719427

7

Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.

Lai EW, Joshi BH, Martiniova L, Dogra R, Fujisawa T, Leland P, de Krijger RR, Lubensky IA, Elkahloun AG, Morris JC, Puri RK, Pacak K. Lai EW, et al. Among authors: joshi bh. J Clin Endocrinol Metab. 2009 Aug;94(8):2952-7. doi: 10.1210/jc.2009-0309. Epub 2009 Jun 2. J Clin Endocrinol Metab. 2009. PMID: 19491224 Free PMC article.

8

Tumor immunology.

Joshi BH, Puri RK. Joshi BH, et al. Curr Mol Med. 2009 Aug;9(6):665-6. doi: 10.2174/156652409788970643. Curr Mol Med. 2009. PMID: 19689292 No abstract available.

9

Targeting of IL-4 and IL-13 receptors for cancer therapy.

Suzuki A, Leland P, Joshi BH, Puri RK. Suzuki A, et al. Among authors: joshi bh. Cytokine. 2015 Sep;75(1):79-88. doi: 10.1016/j.cyto.2015.05.026. Epub 2015 Jun 15. Cytokine. 2015. PMID: 26088753 Review.

10

Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.

Joshi BH, Leland P, Calvo A, Green JE, Puri RK. Joshi BH, et al. Cancer Res. 2008 Nov 15;68(22):9311-7. doi: 10.1158/0008-5472.CAN-08-2810. Cancer Res. 2008. PMID: 19010904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page